The maternie Database:
We collect a lot of women’s health news, every weekday. This is where you’ll find everything we’ve rounded up and reported on postpartum. Want to get this news in your inbox, as soon as we find it? Sign up above.
Study identifies fast, simple method for predicting life-threatening postpartum bleeding.
Ashley Parker writes about the emotional and medical realities of miscarriage, including how the term “abortion” appears in routine procedures.
The Trump administration ends the Pregnancy Risk Assessment Monitoring System (PRAMS), a long-standing CDC data tool.
The New York Times dives into the ethics and limitations of using polygenic screening in IVF, highlighting the probabilistic nature of the predictions.
A blood test may soon predict postpartum depression before symptoms arise.
Carolina Public Press highlights potential solutions to the maternal care crisis in rural areas of North Carolina.
A study identifies patterns in postpartum blood pressure that could help predict future hypertension.
A study of over 350,000 pregnancies found that 11% of women used cannabis before conception, and 6% used it during pregnancy, likely to manage nausea.
A study highlights an increased risk of preterm birth and low birthweight for individuals infected with COVID-19 during pregnancy.
A randomized trial showed virtual education and follow-up via WhatsApp lowered postpartum depression rates.
Study highlights barriers preventing women from obtaining permanent contraception after delivery.
Rutgers researchers preserve and expand the Camden Study data.
Postpartum depression tied to brain changes after childbirth.
NIH-funded study finds that higher vitamin D levels in the first trimester contribute to fetal growth.
British mother calls for better treatment after her daughter’s suicide due to untreated hyperemesis gravidarum.
A one-hour glucose test after pregnancy is more effective in predicting diabetes risk than the traditional two-hour test.
An analysis of five years of U.S. maternal mortality data reveals significant state-to-state differences in causes of death.
A randomized control trial found that postpartum women treated with nifedipine had a dramatically lower readmission rate than those on labetalol.
A retrospective study found that preconception use of GLP-1 medications was associated with reduced risks of several adverse pregnancy outcomes.
A study comparing sisters of women with and without pregnancy complications found that genetic and environmental factors may drive cardiovascular disease risk.